Skip to the shortlist
Peptide ClarityGuide

Your shortlist for body composition

By Peptide Clarity Guide · October 2026

Compare weight-care services and their medication, monitoring and payment arrangements. A provider’s inclusion does not show that adding another prescription preserves muscle or improves an individual’s outcome.

All the body composition providers, In first, then Not yet.

We may earn a commission through qualifying provider links at no extra cost to you. Read our selection criteria and funding disclosure. How we earn

Partners on this list

Partner cards: if you join through one, the provider pays us a fee and your price stays the same. The full list below keeps its pick order.

Made the shortlist

Listed in pick order. See how picks work.

  1. Strut HealthPartner

    GLP-1 injections and lozenges; confirm the formulation, medical need and refill terms.

    Semaglutide injections$130.79/mo
    Visit Strut Health
  2. Compounded GLP-1s, microdose plans and brand Wegovy or Zepbound access in one account.

    Semaglutide pills$349/mo
    Visit AgelessRx
  3. Compounded semaglutide or tirzepatide at one monthly price that holds at every dose.

    Semaglutide injections$89/mo
    Visit altRx
  4. Testosterone as a shot, a spray or a cream, with labs before anything is prescribed.

    Testosterone cream$199/mo
    Visit PauseRx
  5. Compounded semaglutide or tirzepatide, shots or tablets, with no membership fee.

    Semaglutide injections$227.04/mo
    Visit Luvo Health
  6. Gala GLP-1Partner

    Compounded semaglutide or tirzepatide with every dose, app and coaching in one price.

    Semaglutide injectionsPrice on request
    Visit Gala GLP-1
  7. Compounded GLP-1s from four named 503A pharmacies, at the same price at every dose.

    Semaglutide injections$99/mo
    Visit SnagRx
  8. Monthly GLP-1 offers and separate prepaid packs, with state and formulation limits.

    Semaglutide injections$129/mo
    Visit Brightmeds
  9. GLP-1 pages separate introductory payment, supply and the later renewal charge.

    Semaglutide injections$165/mo
    Visit HealthRX
  10. Monthly and quarterly GLP-1 plans need the processing fee added to the base price.

    Semaglutide injections$174.72/mo
    Visit TeleZen MD
  11. GLP-1 injection and tablet offers require the actual prescription-specific total.

    Semaglutide injections$299/mo
    Visit Willow
  12. Public GLP-1 plan choices allow commitment comparisons before requesting a quote.

    Semaglutide injectionsPrice on request
    Visit Lttl
  13. Compounded semaglutide or tirzepatide at one flat price, whatever your dose.

    Semaglutide injections$75.58/mo
    Visit Collective
  14. The FAQ advertises flat pricing across GLP-1 doses; confirm the actual plan terms.

    Semaglutide injectionsPrice shown after a few questions
    Visit CoreAge Rx

Not a pick yet

  • Arc-1 Not yet

    Why: Prints no cancellation terms for its monthly subscriptions.

    When the gap closes, Arc-1 can move to In.

    Read the pick
  • Bayan Health Not yet

    Why: Investigational peptide listings leave the qualifying access pathway unclear.

    When the gap closes, Bayan Health can move to In.

    Read the pick
  • Belle Not yet

    Why: Confirm the dispensing pharmacy, payment schedule and order-stage refund terms.

    When the gap closes, Belle can move to In.

    Read the pick
  • BioGlow Health Not yet

    Why: Approximate month-supply prices do not establish automatic refill charges or dates.

    When the gap closes, BioGlow Health can move to In.

    Read the pick
  • bmiMD Not yet

    Why: Terms describe twenty-eight-to-thirty-day renewal and separate quarterly billing.

    When the gap closes, bmiMD can move to In.

    Read the pick
  • Bodybuilding Health+ Not yet

    Why: Lists Strive Pharmacy but not which Strive site fills your order.

    When the gap closes, Bodybuilding Health+ can move to In.

    Read the pick
  • Defy Medical Not yet

    Why: Medication, testing and consultation costs require an itemized personalized quote.

    When the gap closes, Defy Medical can move to In.

    Read the pick
  • DirectMeds Not yet

    Why: Its BPC-157 listing does not meet the reviewed routine commercial compounding conditions.

    When the gap closes, DirectMeds can move to In.

    Read the pick
  • DudeMeds Not yet

    Why: The reviewed disclosures do not identify the pharmacy filling the selected order.

    When the gap closes, DudeMeds can move to In.

    Read the pick
  • Eden Not yet

    Why: GLP-1 no-membership claims differ from recurring-membership terms.

    When the gap closes, Eden can move to In.

    Read the pick
  • EdgeRx Not yet

    Why: Names Strive Pharmacy as its one pharmacy, but not which Strive site ships.

    When the gap closes, EdgeRx can move to In.

    Read the pick
  • ElitePhysiqMD Not yet

    Why: Its investigational peptide catalog leaves the qualifying access pathway unclear.

    When the gap closes, ElitePhysiqMD can move to In.

    Read the pick
  • ElleS Not yet

    Why: The actual dispensing site and selected payment and refund agreement need confirmation.

    When the gap closes, ElleS can move to In.

    Read the pick
  • Embody Not yet

    Why: Confirm the current renewal amount and charge interval before comparing plans.

    When the gap closes, Embody can move to In.

    Read the pick
  • Enhance MD Not yet

    Why: Its partner lists differ; confirm the actual dispensing pharmacy and site.

    When the gap closes, Enhance MD can move to In.

    Read the pick
  • Found Not yet

    Why: Compounded treatment availability by state is not established by its insurance map.

    When the gap closes, Found can move to In.

    Read the pick
  • Fridays Not yet

    Why: TRT medication is extra; GLP-1 promotional totals need a selected renewal quote.

    When the gap closes, Fridays can move to In.

    Read the pick
  • GoodLife Health Not yet

    Why: Medication is billed by the pharmacy, and no monthly drug price is published.

    When the gap closes, GoodLife Health can move to In.

    Read the pick
  • HumeCare+ Not yet

    Why: Introductory homepage pricing does not establish the full prepaid renewal agreement.

    When the gap closes, HumeCare+ can move to In.

    Read the pick
  • KIN Meds Not yet

    Why: Starting hormone offers do not settle the selected form, testing and recurring total.

    When the gap closes, KIN Meds can move to In.

    Read the pick
  • MangoRx Not yet

    Why: The TRT testing offer and laboratory costs leave the full medication renewal unclear.

    When the gap closes, MangoRx can move to In.

    Read the pick
  • MEDGm Not yet

    Why: Early charges and term billing require the selected payment schedule in writing.

    When the gap closes, MEDGm can move to In.

    Read the pick
  • MEDVi Not yet

    Why: Product pages contain unresolved numerical compounded-plan price fields.

    When the gap closes, MEDVi can move to In.

    Read the pick
  • Next Vial Not yet

    Why: Starting offers and differing GLP-1 pages leave selected renewal charges unconfirmed.

    When the gap closes, Next Vial can move to In.

    Read the pick
  • Nova Not yet

    Why: Prescribing-decline fees and medication and membership charges need clarification.

    When the gap closes, Nova can move to In.

    Read the pick
  • Oak Not yet

    Why: Lists tesamorelin without saying whether it's the brand drug or compounded.

    When the gap closes, Oak can move to In.

    Read the pick
  • PeterMD Not yet

    Why: Confirm the dispensing facility, current authorization and actual recurring agreement.

    When the gap closes, PeterMD can move to In.

    Read the pick
  • RNK Health Not yet

    Why: Inclusive-price claims differ from terms allowing separate pharmacy fees.

    When the gap closes, RNK Health can move to In.

    Read the pick
  • Science & Co Not yet

    Why: Annual headlines do not establish the selected ongoing invoice and charge interval.

    When the gap closes, Science & Co can move to In.

    Read the pick
  • SkinnyRx Not yet

    Why: Current introductory GLP-1 offers do not establish the later renewal charge.

    When the gap closes, SkinnyRx can move to In.

    Read the pick
  • Sprout Health Not yet

    Why: Four-week product renewal differs from monthly policy and legacy payment instructions.

    When the gap closes, Sprout Health can move to In.

    Read the pick
  • System Labs Not yet

    Why: Homepage and product offers differ; crossed-out figures do not establish renewal.

    When the gap closes, System Labs can move to In.

    Read the pick
  • TrimRx Not yet

    Why: Homepage and terms show different offers; confirm the selected payment schedule.

    When the gap closes, TrimRx can move to In.

    Read the pick
  • Tyde Wellness Not yet

    Why: The exact longevity formulation and qualifying access pathway need confirmation.

    When the gap closes, Tyde Wellness can move to In.

    Read the pick
  • Wellorithm Not yet

    Why: Monthly pricing and twenty-eight-day terms describe different renewal schedules.

    When the gap closes, Wellorithm can move to In.

    Read the pick
  • WePeptideRx Not yet

    Why: Dose-selector prices differ from the same product page’s overview.

    When the gap closes, WePeptideRx can move to In.

    Read the pick

What the rules check, and what to expect

Each one had to pass six rules. A clinician stands between you and the pharmacy. The month-to-month cost is on the page before checkout. The pharmacy is licensed in the US, nothing on the menu is a research-use peptide, the way out is in writing, and new patients can actually enroll. See How picks work for the full text.

Trials of approved semaglutide and tirzepatide products show weight loss in specific populations and regimens. Those results do not establish equivalence for compounded preparations. Weight loss can include lean mass, so read whether you can build muscle on tirzepatide. Then compare semaglutide and tirzepatide side by side.

How to choose between the picks

  • Track the outcome you actually value. A lower scale weight does not reveal how much change was fat, water or lean tissue. DXA lean soft tissue is also different from a direct muscle-strength measurement. Ask whether the care plan follows practical function as well as body weight. Training performance or a clinician-selected functional measure can answer a different question from a scan. Avoid treating every reported lean-mass change as the same amount of muscle lost.
  • Identify the exact weight-care product. Approved injections, approved tablets and compounded preparations are distinct purchases. Trial results belong to the molecule, formulation and regimen studied. An oral option should be named precisely rather than advertised as the needle-free equivalent of every shot. Check whether medication is included in the quoted service or purchased elsewhere. A familiar ingredient name does not settle quality, absorption or expected response.
  • Plan support for eating and physical activity. Ask whether nutrition appointments and resistance-training support are actually included. Advertised coaching can mean different things from an appointment with a qualified dietitian. Discuss how the program responds when appetite changes make adequate eating difficult. Establish who coordinates those concerns with the prescribing clinician. A large supplement or hormone catalog is not a substitute for that practical support.
  • Question every proposed muscle add-on. Sermorelin or testosterone can satisfy this page’s product filter without having proven muscle-preserving effects during GLP-1 treatment. Each additional prescription needs its own indication, risk assessment and follow-up. Ask which study tested the proposed combination in a population resembling yours. A growth-hormone marker rising does not demonstrate improved strength. Keep the extra medication, laboratory and visit costs separate when deciding whether the proposal makes sense.

Questions about this list

What does a GLP-1 program cost each month?
Compounded semaglutide shots run $75.58–$349 a month and compounded tirzepatide runs $85.58–$433.44 a month, counting providers with a public price. Compare brand-medication costs and any separate membership on their actual selected terms. Cards identify the product their figure covers.
Will I lose muscle along with fat?
Some. In a tirzepatide body-scan study, about three quarters of the weight lost was fat and a quarter was lean mass, the same split seen with placebo. Strength training and enough protein help protect muscle.
Is compounded semaglutide the same as Wegovy?
A familiar ingredient name does not establish the same finished product, quality, absorption or outcome. Compounded preparations are not FDA-approved or reviewed through that approval process. Wegovy is the approved brand. The pick card tells you which one you're paying for.
Does sermorelin help with body composition?
Its inclusion reflects the comparison’s product scope, rather than an established muscle-preservation benefit. Small adult GHRH studies differ in molecule and design; hormone changes do not prove clinical benefit from a current compounded sermorelin preparation.

This is general information, not medical advice. A licensed clinician can tell you what fits you. Health note